The analysis of the checkpoint proteins expression in the bone marrow of MDS and AML patients demonstrated that myeloid cells express different checkpoint ligands and receptors, including CD80, CD86 and PD-1L [14–16]. Here, CD80 is linked to myelodysplastic syndrome.